Tin Su
Concepts (311)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Drosophila melanogaster | 28 | 2024 | 217 | 7.340 |
Why?
| Drosophila Proteins | 22 | 2022 | 187 | 5.420 |
Why?
| Drosophila | 17 | 2019 | 143 | 4.620 |
Why?
| Radiation, Ionizing | 12 | 2020 | 75 | 2.430 |
Why?
| Cell Cycle | 17 | 2020 | 581 | 2.220 |
Why?
| Regeneration | 6 | 2022 | 175 | 2.130 |
Why?
| Apoptosis | 16 | 2024 | 2437 | 2.120 |
Why?
| DNA Damage | 15 | 2020 | 364 | 1.610 |
Why?
| Caspases | 4 | 2020 | 242 | 1.540 |
Why?
| Mitosis | 11 | 2011 | 178 | 1.480 |
Why?
| Imaginal Discs | 5 | 2019 | 5 | 1.430 |
Why?
| Wings, Animal | 7 | 2022 | 40 | 1.310 |
Why?
| Wnt1 Protein | 3 | 2022 | 7 | 1.310 |
Why?
| Tumor Suppressor Protein p53 | 6 | 2020 | 507 | 1.180 |
Why?
| STAT Transcription Factors | 2 | 2017 | 14 | 1.110 |
Why?
| Cell Cycle Proteins | 10 | 2017 | 580 | 1.100 |
Why?
| High-Throughput Screening Assays | 2 | 2023 | 136 | 1.080 |
Why?
| Neoplasms | 6 | 2023 | 2465 | 1.060 |
Why?
| Animals | 58 | 2024 | 34501 | 1.060 |
Why?
| Stem Cells | 3 | 2018 | 578 | 0.990 |
Why?
| Loss of Heterozygosity | 2 | 2024 | 46 | 0.930 |
Why?
| Chromosomes | 2 | 2024 | 101 | 0.930 |
Why?
| Peptides, Cyclic | 3 | 2020 | 255 | 0.930 |
Why?
| Cell Death | 5 | 2018 | 348 | 0.870 |
Why?
| Radiation Tolerance | 3 | 2014 | 97 | 0.850 |
Why?
| Radiation-Sensitizing Agents | 2 | 2015 | 40 | 0.850 |
Why?
| Transcription Factor AP-1 | 1 | 2023 | 85 | 0.830 |
Why?
| Models, Biological | 11 | 2020 | 1693 | 0.810 |
Why?
| Larva | 8 | 2022 | 210 | 0.810 |
Why?
| Spindle Apparatus | 6 | 2011 | 93 | 0.800 |
Why?
| Drug Discovery | 2 | 2023 | 130 | 0.780 |
Why?
| Embryo, Nonmammalian | 6 | 2011 | 167 | 0.730 |
Why?
| Intracellular Signaling Peptides and Proteins | 3 | 2021 | 425 | 0.710 |
Why?
| Gene Expression Profiling | 2 | 2022 | 1687 | 0.710 |
Why?
| DNA Repair | 6 | 2020 | 205 | 0.710 |
Why?
| Wound Healing | 1 | 2023 | 310 | 0.700 |
Why?
| Transcription Factors | 4 | 2022 | 1631 | 0.670 |
Why?
| Tumor Suppressor Proteins | 3 | 2021 | 312 | 0.660 |
Why?
| Peptide Hydrolases | 1 | 2020 | 106 | 0.660 |
Why?
| Salivary Glands | 1 | 2019 | 29 | 0.640 |
Why?
| Gastrula | 3 | 2004 | 17 | 0.630 |
Why?
| Drugs, Investigational | 1 | 2019 | 32 | 0.630 |
Why?
| Drug Evaluation, Preclinical | 1 | 2019 | 168 | 0.610 |
Why?
| DNA Replication | 3 | 2010 | 224 | 0.580 |
Why?
| Nuclear Proteins | 4 | 2009 | 648 | 0.580 |
Why?
| Pyrophosphatases | 1 | 2017 | 21 | 0.570 |
Why?
| E2F1 Transcription Factor | 2 | 2024 | 61 | 0.560 |
Why?
| Gene Expression Regulation, Developmental | 7 | 2022 | 815 | 0.550 |
Why?
| Microtubule-Associated Proteins | 2 | 2009 | 189 | 0.520 |
Why?
| Autophagy | 1 | 2018 | 266 | 0.520 |
Why?
| Signal Transduction | 7 | 2024 | 4829 | 0.510 |
Why?
| Models, Animal | 1 | 2017 | 367 | 0.510 |
Why?
| Disease Models, Animal | 5 | 2020 | 3943 | 0.500 |
Why?
| MicroRNAs | 2 | 2014 | 671 | 0.470 |
Why?
| Research | 1 | 2017 | 409 | 0.460 |
Why?
| Drug Screening Assays, Antitumor | 2 | 2012 | 194 | 0.460 |
Why?
| Methyl Methanesulfonate | 3 | 2010 | 5 | 0.450 |
Why?
| Protein-Tyrosine Kinases | 2 | 2009 | 430 | 0.450 |
Why?
| Epithelial Cells | 2 | 2017 | 1036 | 0.430 |
Why?
| Mutation | 12 | 2020 | 3692 | 0.420 |
Why?
| Mutagens | 3 | 2010 | 17 | 0.420 |
Why?
| Heterozygote | 3 | 2024 | 266 | 0.420 |
Why?
| DNA-Binding Proteins | 6 | 2022 | 1415 | 0.400 |
Why?
| Genome, Insect | 1 | 2012 | 21 | 0.400 |
Why?
| Neuropeptides | 2 | 2009 | 72 | 0.390 |
Why?
| Chromosome Aberrations | 2 | 2024 | 147 | 0.380 |
Why?
| Cyclin A | 2 | 2001 | 17 | 0.370 |
Why?
| Maytansine | 1 | 2011 | 16 | 0.370 |
Why?
| DNA, Satellite | 1 | 2010 | 17 | 0.360 |
Why?
| Paclitaxel | 1 | 2012 | 214 | 0.360 |
Why?
| Hydrozoa | 1 | 2010 | 1 | 0.350 |
Why?
| E2F2 Transcription Factor | 1 | 2010 | 15 | 0.350 |
Why?
| Membrane Proteins | 1 | 2017 | 1108 | 0.350 |
Why?
| Cell Division | 3 | 2005 | 779 | 0.350 |
Why?
| Heterochromatin | 1 | 2010 | 41 | 0.350 |
Why?
| Metabolic Networks and Pathways | 1 | 2011 | 175 | 0.350 |
Why?
| Biology | 1 | 2011 | 83 | 0.330 |
Why?
| Cell Survival | 4 | 2022 | 1077 | 0.330 |
Why?
| Protein Kinases | 4 | 2021 | 309 | 0.320 |
Why?
| Tyrosine | 1 | 2009 | 216 | 0.310 |
Why?
| Teaching | 1 | 2011 | 209 | 0.310 |
Why?
| Leprosy | 2 | 2019 | 14 | 0.300 |
Why?
| Educational Measurement | 1 | 2011 | 261 | 0.300 |
Why?
| CDC2 Protein Kinase | 3 | 2005 | 31 | 0.300 |
Why?
| Cyclin E | 2 | 2007 | 23 | 0.290 |
Why?
| Combined Modality Therapy | 5 | 2020 | 1209 | 0.290 |
Why?
| Cell Movement | 2 | 2019 | 937 | 0.280 |
Why?
| Phosphorylation | 7 | 2009 | 1681 | 0.280 |
Why?
| Humans | 26 | 2024 | 128524 | 0.260 |
Why?
| Genes, cdc | 3 | 2006 | 11 | 0.250 |
Why?
| Telomere | 2 | 2006 | 226 | 0.240 |
Why?
| Students | 1 | 2011 | 573 | 0.240 |
Why?
| Anaphase | 2 | 2005 | 15 | 0.240 |
Why?
| Metaphase | 2 | 2005 | 29 | 0.240 |
Why?
| Gene Expression Regulation | 3 | 2009 | 2506 | 0.240 |
Why?
| Head and Neck Neoplasms | 2 | 2020 | 534 | 0.240 |
Why?
| Cisplatin | 2 | 2024 | 297 | 0.230 |
Why?
| Chromosomal Instability | 1 | 2004 | 18 | 0.230 |
Why?
| Tubulin | 1 | 2005 | 138 | 0.220 |
Why?
| CDC2-CDC28 Kinases | 1 | 2004 | 20 | 0.220 |
Why?
| Peroxiredoxins | 1 | 2024 | 24 | 0.220 |
Why?
| Curriculum | 1 | 2011 | 921 | 0.220 |
Why?
| Arthropods | 1 | 2004 | 9 | 0.220 |
Why?
| Photoreceptor Cells, Invertebrate | 1 | 2003 | 4 | 0.220 |
Why?
| Vertebrates | 1 | 2004 | 58 | 0.210 |
Why?
| Flow Cytometry | 3 | 2022 | 1141 | 0.210 |
Why?
| Telomere-Binding Proteins | 1 | 2004 | 102 | 0.210 |
Why?
| Organogenesis | 1 | 2003 | 57 | 0.210 |
Why?
| Cytoskeleton | 1 | 2004 | 180 | 0.210 |
Why?
| Gene Expression | 2 | 2018 | 1462 | 0.200 |
Why?
| Immunoprecipitation | 3 | 2009 | 157 | 0.200 |
Why?
| Cell Proliferation | 5 | 2017 | 2335 | 0.200 |
Why?
| Cell Line | 4 | 2023 | 2731 | 0.200 |
Why?
| Cell Separation | 2 | 2022 | 313 | 0.190 |
Why?
| Tyrosine 3-Monooxygenase | 1 | 2001 | 72 | 0.190 |
Why?
| Protein Biosynthesis | 2 | 2015 | 397 | 0.190 |
Why?
| Microscopy, Confocal | 4 | 2007 | 308 | 0.190 |
Why?
| Cell Plasticity | 1 | 2022 | 27 | 0.190 |
Why?
| Checkpoint Kinase 2 | 4 | 2010 | 23 | 0.190 |
Why?
| Neurofibromin 2 | 2 | 2021 | 3 | 0.190 |
Why?
| Alleles | 2 | 2020 | 845 | 0.190 |
Why?
| Xenograft Model Antitumor Assays | 4 | 2020 | 810 | 0.180 |
Why?
| Cell Line, Tumor | 4 | 2020 | 3160 | 0.180 |
Why?
| MAP Kinase Signaling System | 2 | 2019 | 302 | 0.180 |
Why?
| Blotting, Western | 4 | 2009 | 1168 | 0.170 |
Why?
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2020 | 39 | 0.170 |
Why?
| Phthalazines | 1 | 2020 | 39 | 0.170 |
Why?
| Cetuximab | 1 | 2020 | 94 | 0.170 |
Why?
| Intracellular Space | 1 | 2020 | 71 | 0.170 |
Why?
| Immunogenicity, Vaccine | 1 | 2020 | 26 | 0.170 |
Why?
| RNA Interference | 3 | 2019 | 440 | 0.170 |
Why?
| Biological Evolution | 1 | 2004 | 426 | 0.170 |
Why?
| Protein Synthesis Inhibitors | 1 | 2020 | 41 | 0.170 |
Why?
| Apoptosis Regulatory Proteins | 1 | 2020 | 182 | 0.160 |
Why?
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2020 | 90 | 0.160 |
Why?
| Diacylglycerol Kinase | 1 | 2019 | 5 | 0.160 |
Why?
| rac GTP-Binding Proteins | 1 | 2019 | 32 | 0.160 |
Why?
| Chemotherapy, Adjuvant | 1 | 2020 | 376 | 0.160 |
Why?
| DNA | 2 | 2005 | 1392 | 0.160 |
Why?
| Radiobiology | 1 | 2019 | 5 | 0.160 |
Why?
| Embryo, Mammalian | 1 | 2000 | 226 | 0.160 |
Why?
| Embryonic Development | 1 | 2000 | 115 | 0.160 |
Why?
| Protein Tyrosine Phosphatases | 1 | 2000 | 160 | 0.160 |
Why?
| Adjuvants, Immunologic | 1 | 2020 | 221 | 0.150 |
Why?
| Cancer Vaccines | 1 | 2020 | 165 | 0.150 |
Why?
| Molecular Imaging | 1 | 2019 | 55 | 0.150 |
Why?
| JNK Mitogen-Activated Protein Kinases | 1 | 2018 | 160 | 0.150 |
Why?
| Checkpoint Kinase 1 | 4 | 2006 | 31 | 0.150 |
Why?
| Piperazines | 1 | 2020 | 334 | 0.150 |
Why?
| Phenotype | 3 | 2018 | 3050 | 0.140 |
Why?
| Transients and Migrants | 1 | 2017 | 24 | 0.140 |
Why?
| S Phase | 2 | 2010 | 73 | 0.140 |
Why?
| Gene Silencing | 2 | 2016 | 185 | 0.140 |
Why?
| Neoplasm Proteins | 1 | 2020 | 421 | 0.140 |
Why?
| Antigens, Neoplasm | 1 | 2020 | 310 | 0.140 |
Why?
| Protein Transport | 1 | 2018 | 422 | 0.140 |
Why?
| Cell Lineage | 1 | 2018 | 333 | 0.140 |
Why?
| Cell Culture Techniques | 1 | 2019 | 345 | 0.130 |
Why?
| Radiation Injuries, Experimental | 1 | 2016 | 22 | 0.130 |
Why?
| Cell Polarity | 1 | 2017 | 140 | 0.130 |
Why?
| Cells, Cultured | 2 | 2019 | 4008 | 0.130 |
Why?
| Neoplastic Stem Cells | 1 | 2020 | 384 | 0.120 |
Why?
| Receptors, TIE | 1 | 2015 | 1 | 0.120 |
Why?
| Immunotherapy | 1 | 2020 | 585 | 0.120 |
Why?
| Cost of Illness | 1 | 2017 | 288 | 0.120 |
Why?
| Reproducibility of Results | 1 | 2023 | 3023 | 0.120 |
Why?
| Genetic Testing | 1 | 2017 | 427 | 0.120 |
Why?
| Fluorescent Antibody Technique | 2 | 2005 | 374 | 0.110 |
Why?
| Time Factors | 5 | 2005 | 6503 | 0.110 |
Why?
| Morphogenesis | 2 | 2005 | 156 | 0.110 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2015 | 283 | 0.110 |
Why?
| HeLa Cells | 1 | 2015 | 603 | 0.110 |
Why?
| Cyclin-Dependent Kinases | 2 | 2004 | 130 | 0.100 |
Why?
| Dose-Response Relationship, Radiation | 2 | 2020 | 132 | 0.100 |
Why?
| X-Rays | 2 | 2004 | 29 | 0.100 |
Why?
| Colorectal Neoplasms | 1 | 2020 | 753 | 0.100 |
Why?
| M Phase Cell Cycle Checkpoints | 1 | 2011 | 24 | 0.090 |
Why?
| Brain | 1 | 2004 | 2618 | 0.090 |
Why?
| Glioma | 1 | 2015 | 352 | 0.090 |
Why?
| Embryology | 1 | 2011 | 1 | 0.090 |
Why?
| HCT116 Cells | 1 | 2011 | 78 | 0.090 |
Why?
| Tuberous Sclerosis | 1 | 2011 | 49 | 0.090 |
Why?
| Mitotic Index | 1 | 2010 | 26 | 0.090 |
Why?
| Drug Design | 1 | 2011 | 155 | 0.090 |
Why?
| Mental Disorders | 1 | 2019 | 1007 | 0.090 |
Why?
| Mice | 5 | 2020 | 16579 | 0.090 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 756 | 0.080 |
Why?
| Green Fluorescent Proteins | 2 | 2008 | 382 | 0.080 |
Why?
| Cell Nucleus | 2 | 2003 | 579 | 0.080 |
Why?
| Goals | 1 | 2011 | 162 | 0.080 |
Why?
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2009 | 136 | 0.080 |
Why?
| Amino Acid Sequence | 2 | 2003 | 2041 | 0.080 |
Why?
| Peer Group | 1 | 2011 | 225 | 0.080 |
Why?
| Mutagenesis, Site-Directed | 1 | 2009 | 358 | 0.080 |
Why?
| Molecular Sequence Data | 2 | 2003 | 2818 | 0.080 |
Why?
| Biological Products | 1 | 2012 | 200 | 0.080 |
Why?
| Gene Deletion | 2 | 2015 | 372 | 0.070 |
Why?
| Kinetochores | 1 | 2008 | 49 | 0.070 |
Why?
| China | 2 | 2019 | 191 | 0.070 |
Why?
| Survival Analysis | 1 | 2011 | 1265 | 0.070 |
Why?
| Xenopus | 2 | 2005 | 85 | 0.070 |
Why?
| Gene Dosage | 1 | 2008 | 142 | 0.070 |
Why?
| 3' Untranslated Regions | 1 | 2008 | 136 | 0.070 |
Why?
| Biomarkers | 1 | 2018 | 3881 | 0.070 |
Why?
| Quality of Life | 1 | 2019 | 2680 | 0.070 |
Why?
| E2F Transcription Factors | 1 | 2007 | 59 | 0.070 |
Why?
| Brain Neoplasms | 1 | 2015 | 1149 | 0.070 |
Why?
| Learning | 1 | 2011 | 390 | 0.070 |
Why?
| Cytokinesis | 1 | 2007 | 48 | 0.070 |
Why?
| Gastrin-Releasing Peptide | 1 | 2005 | 7 | 0.060 |
Why?
| Microscopy, Fluorescence | 2 | 2005 | 402 | 0.060 |
Why?
| Electrophoresis, Gel, Two-Dimensional | 1 | 2005 | 96 | 0.060 |
Why?
| Chromatography, Affinity | 1 | 2005 | 83 | 0.060 |
Why?
| DNA Breaks, Double-Stranded | 1 | 2006 | 37 | 0.060 |
Why?
| Centrosome | 1 | 2005 | 64 | 0.060 |
Why?
| Female | 8 | 2020 | 68127 | 0.060 |
Why?
| Acid Anhydride Hydrolases | 1 | 2004 | 6 | 0.060 |
Why?
| Transgenes | 1 | 2005 | 177 | 0.060 |
Why?
| RNA, Messenger | 1 | 2012 | 2674 | 0.060 |
Why?
| DNA Repair Enzymes | 1 | 2004 | 21 | 0.060 |
Why?
| Enzyme Activation | 1 | 2006 | 799 | 0.060 |
Why?
| Ataxia Telangiectasia Mutated Proteins | 1 | 2004 | 64 | 0.060 |
Why?
| Models, Genetic | 2 | 2006 | 590 | 0.060 |
Why?
| Sequence Analysis, DNA | 2 | 2006 | 773 | 0.060 |
Why?
| Cleavage Stage, Ovum | 1 | 2004 | 6 | 0.060 |
Why?
| Egg Proteins | 1 | 2004 | 17 | 0.060 |
Why?
| Retinoblastoma Protein | 1 | 2004 | 54 | 0.060 |
Why?
| Embryonic and Fetal Development | 1 | 2004 | 94 | 0.060 |
Why?
| Invertebrates | 1 | 2004 | 23 | 0.060 |
Why?
| Cyclin-Dependent Kinase 2 | 1 | 2004 | 38 | 0.060 |
Why?
| Bromodeoxyuridine | 1 | 2004 | 77 | 0.060 |
Why?
| Gene Targeting | 1 | 2004 | 82 | 0.060 |
Why?
| Fertilization | 1 | 2004 | 42 | 0.050 |
Why?
| Macromolecular Substances | 1 | 2004 | 211 | 0.050 |
Why?
| X Chromosome | 1 | 2003 | 51 | 0.050 |
Why?
| Models, Anatomic | 1 | 2004 | 92 | 0.050 |
Why?
| Crosses, Genetic | 1 | 2003 | 141 | 0.050 |
Why?
| Substrate Specificity | 1 | 2004 | 367 | 0.050 |
Why?
| Body Patterning | 1 | 2004 | 128 | 0.050 |
Why?
| Sequence Alignment | 1 | 2003 | 330 | 0.050 |
Why?
| Sequence Homology, Amino Acid | 1 | 2003 | 368 | 0.050 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 937 | 0.050 |
Why?
| Male | 6 | 2019 | 62883 | 0.050 |
Why?
| DNA Transposable Elements | 1 | 2003 | 119 | 0.050 |
Why?
| Mass Spectrometry | 1 | 2005 | 660 | 0.050 |
Why?
| Recombination, Genetic | 1 | 2003 | 188 | 0.050 |
Why?
| Mammals | 1 | 2004 | 269 | 0.050 |
Why?
| Structure-Activity Relationship | 1 | 2003 | 530 | 0.050 |
Why?
| Telomerase | 1 | 2004 | 231 | 0.050 |
Why?
| Fertility | 1 | 2003 | 162 | 0.050 |
Why?
| 14-3-3 Proteins | 1 | 2001 | 17 | 0.050 |
Why?
| Protein Processing, Post-Translational | 1 | 2004 | 450 | 0.050 |
Why?
| Saccharomyces cerevisiae | 1 | 2005 | 522 | 0.050 |
Why?
| Reactive Oxygen Species | 1 | 2024 | 579 | 0.050 |
Why?
| Cytoplasm | 1 | 2001 | 258 | 0.040 |
Why?
| Amino Acid Motifs | 1 | 2001 | 209 | 0.040 |
Why?
| Temperature | 1 | 2004 | 625 | 0.040 |
Why?
| DNA End-Joining Repair | 1 | 2020 | 18 | 0.040 |
Why?
| Ubiquitination | 1 | 2021 | 97 | 0.040 |
Why?
| Proof of Concept Study | 1 | 2020 | 64 | 0.040 |
Why?
| Blastoderm | 1 | 2000 | 1 | 0.040 |
Why?
| Theranostic Nanomedicine | 1 | 2020 | 12 | 0.040 |
Why?
| Clone Cells | 1 | 2020 | 254 | 0.040 |
Why?
| Proteolysis | 1 | 2021 | 161 | 0.040 |
Why?
| DNA, Neoplasm | 1 | 2020 | 159 | 0.040 |
Why?
| Peptide Chain Elongation, Translational | 1 | 2020 | 18 | 0.040 |
Why?
| Phosphoprotein Phosphatases | 1 | 2000 | 67 | 0.040 |
Why?
| Cell Size | 1 | 2000 | 87 | 0.040 |
Why?
| Drug Synergism | 1 | 2020 | 358 | 0.040 |
Why?
| Cyclins | 1 | 2000 | 85 | 0.040 |
Why?
| Staining and Labeling | 1 | 2000 | 139 | 0.040 |
Why?
| Antineoplastic Agents | 1 | 2011 | 2058 | 0.040 |
Why?
| Immunohistochemistry | 1 | 2004 | 1669 | 0.040 |
Why?
| Radiotherapy Dosage | 1 | 2020 | 248 | 0.040 |
Why?
| Base Sequence | 1 | 2003 | 2134 | 0.040 |
Why?
| Heat-Shock Response | 1 | 2000 | 71 | 0.040 |
Why?
| Phylogeny | 1 | 2003 | 846 | 0.040 |
Why?
| Cell Count | 1 | 2000 | 314 | 0.040 |
Why?
| Nanotechnology | 1 | 2020 | 119 | 0.040 |
Why?
| Antigen Presentation | 1 | 2020 | 204 | 0.040 |
Why?
| Mice, Nude | 1 | 2020 | 682 | 0.040 |
Why?
| Dose-Response Relationship, Drug | 1 | 2003 | 1943 | 0.040 |
Why?
| Histones | 1 | 2004 | 581 | 0.040 |
Why?
| Chemoradiotherapy | 1 | 2020 | 209 | 0.040 |
Why?
| Programmed Cell Death 1 Receptor | 1 | 2020 | 226 | 0.040 |
Why?
| Antineoplastic Agents, Immunological | 1 | 2020 | 173 | 0.040 |
Why?
| Microscopy | 1 | 2019 | 140 | 0.040 |
Why?
| Cross-Sectional Studies | 2 | 2019 | 5040 | 0.030 |
Why?
| Mice, Knockout | 1 | 2004 | 2752 | 0.030 |
Why?
| ErbB Receptors | 1 | 2020 | 601 | 0.030 |
Why?
| Kidney | 1 | 2024 | 1305 | 0.030 |
Why?
| Dendritic Cells | 1 | 2020 | 477 | 0.030 |
Why?
| Nanoparticles | 1 | 2020 | 368 | 0.030 |
Why?
| Extracellular Matrix | 1 | 2000 | 497 | 0.030 |
Why?
| Receptor, TIE-2 | 1 | 2015 | 12 | 0.030 |
Why?
| Protein Binding | 1 | 2021 | 2097 | 0.030 |
Why?
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 1333 | 0.030 |
Why?
| Transcription, Genetic | 1 | 2021 | 1398 | 0.030 |
Why?
| Neoplasm Recurrence, Local | 1 | 2020 | 957 | 0.030 |
Why?
| T-Lymphocytes | 1 | 2020 | 1922 | 0.020 |
Why?
| Middle Aged | 2 | 2019 | 30893 | 0.020 |
Why?
| Surveys and Questionnaires | 1 | 2019 | 5346 | 0.020 |
Why?
| Adult | 2 | 2019 | 35315 | 0.020 |
Why?
| Xenopus Proteins | 1 | 2005 | 35 | 0.020 |
Why?
| G2 Phase | 1 | 2005 | 36 | 0.020 |
Why?
| Hydroxyurea | 1 | 2005 | 31 | 0.020 |
Why?
| DNA, Complementary | 1 | 2005 | 267 | 0.010 |
Why?
| RNA-Binding Proteins | 1 | 2006 | 379 | 0.010 |
Why?
| Young Adult | 1 | 2017 | 12320 | 0.010 |
Why?
| Aged | 1 | 2019 | 21971 | 0.010 |
Why?
| RNA | 1 | 2005 | 881 | 0.010 |
Why?
|
|
Su's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|